Skip to content
YCW22· Other

Actipulse Neuroscience

Bringing non-invasive brain stimulation from the hospital to the home

ActiveChecked 19h ago
Batch
W22
Status, per YC
Active
Team size
38
HQ
Mexico City, CDMX
In W22398 companies, 44% AI

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Actipulse Neuroscience

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Mexico City, CDMX, Mexico

Actipulse Neuroscience: questions

Which YC batch was Actipulse Neuroscience in?

Actipulse Neuroscience was in Y Combinator's Winter 2022 batch (W22).

Is Actipulse Neuroscience still active?

Y Combinator lists Actipulse Neuroscience as active.

Where is Actipulse Neuroscience based?

Actipulse Neuroscience lists Mexico City, CDMX, Mexico as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.